Portfolio company
Yumanity Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
Samsara Therapeutics
This company develops autophagy-activating small molecule therapeutics to treat neurodegenerative and age-related diseases for patients with conditions such as ALS and Parkinson’s.
QurAlis
This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.
NRG Therapeutics
This neuroscience company develops small molecule medicines targeting mitochondrial dysfunction to treat patients with Parkinson's and amyotrophic lateral sclerosis.
Vanqua Bio
This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.
Cognition Therapeutics
This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
